HAMIMED M
| : | - | |
|---|---|---|
| Membre du laboratoire | : | Non |
| Organisme | : | - |
| Equipes | : | - |
Références (1)
ACL
Greillier L, Monville F, Leca V, Vely F, Garcia-Filipe S, Ciccolini J, Sabatier F, Ferrani G, Boudai N, Ghezali L, Landri M, Marin C, Hamimed M, Arnaud L, Karlsen M, Atsou K, Bokobza S, Fleury P, Boyer A, Audigier-Valette C, Martinez S, Pegliasco H, Ray P, Falchero L, Serre A, Cloarec N, Lebas L, Hominal S, Barré P, Zahi S, Frikha A, Bory P, Ray ML, Laborde L, Martin V, Malkoun R, Roumieux M, Mazieres J, Pérol M, Vivier E, Benzekry S, Fieschi J, Barlesi F (2022) Abstract LB120: Comprehensive biomarkers analysis to explain resistances to PD1-L1 ICIs: The precision immuno-oncology for advanced non-small cell lung cancer (PIONeeR) trial. Cancer res 82 | doi: 10.1158/1538-7445.AM2022-LB120